Thieblemont Figure 3.
Thieblemont Figure 3. Overall and freedom-from-progression (FFP) survivals of the 424 patients with marginal zone lymphoma (MZL) treated in CHLS between 1988 and June 2005.

Overall and freedom-from-progression (FFP) survivals of the 424 patients with marginal zone lymphoma (MZL) treated in CHLS between 1988 and June 2005.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal